Welcome to our dedicated page for Waldencast news (Ticker: WALD), a resource for investors and traders seeking the latest updates and insights on Waldencast stock.
Waldencast plc operates as a global multi-brand beauty and wellness platform built around Obagi Medical and Milk Makeup. News about WALD commonly covers brand-level product launches, physician-dispensed skincare, cosmetics, suncare, and aesthetic offerings, including Obagi's advanced skincare products and Obagi® saypha® MagIQ™ hyaluronic acid filler.
Company updates also include quarterly and annual financial results, segment performance, channel and distribution developments, clinical-evidence collaborations for aesthetic products, supply-chain and credit-facility actions, and governance or reporting matters tied to financial restatements, internal control over financial reporting, and regulatory review.
Waldencast plc has officially begun trading on the Nasdaq under the ticker symbol WALD, after completing a merger with Obagi Skincare and Milk Makeup on July 27, 2022. The combined entity aims to create a leading beauty and wellness platform focused on developing purpose-driven brands. CEO Michel Brousset emphasized the company's commitment to empowering brands like Obagi and Milk Makeup. The leadership will remain intact for both skincare brands, with each dedicated to enhancing their market presence while aligning with Waldencast's vision for operational excellence.
Waldencast plc has announced the completion of its merger with Obagi Skincare and Milk Makeup, set to trade on Nasdaq under the ticker symbol WALD beginning July 28, 2022. The company aims to create a leading beauty and wellness platform, enhancing the growth of its brands through operational support while preserving their unique identities. CEO Michel Brousset emphasized the merger as a pivotal step towards building a conscious brand portfolio, while Executive Chairman Felipe Dutra expressed confidence in the group's capabilities to navigate the beauty market.
Waldencast Acquisition Corp. (NASDAQ: WALD) announced that its shareholders overwhelmingly approved the business combination with Obagi Skincare and Milk Makeup, with approximately 98% support. The merger is expected to close around July 27, 2022, pending all closing conditions. Post-merger, the combined entity will be named Waldencast plc and trade under the ticker 'WALD' on Nasdaq. This merger marks a strategic move for Waldencast to establish a multi-brand beauty platform, integrating well-known skin and makeup brands.
Waldencast Acquisition Corp. (NASDAQ: WALD) has announced an extraordinary general meeting for its shareholders on July 25, 2022, to vote on the proposed business combination with Obagi Skincare and Milk Makeup. The SEC has declared effective the registration statement related to this deal. If approved, the merger will position the combined entity on Nasdaq under the symbol WALD. Shareholders are encouraged to vote 'FOR' all proposals and to review the definitive proxy statement thoroughly before the meeting.
Waldencast Acquisition Corp. (NASDAQ: WALD) announced a new Credit Agreement on June 24, 2022, through its subsidiary, Waldencast Finco Limited. The agreement secures proceeds of up to approximately $1.02 billion, contingent on shareholder actions. Key components include a $175 million term loan and a revolving loan of up to $50 million. The financing will primarily be used for acquisitions of Milk Makeup and Obagi Skin Care, repayment of existing debts, and general corporate purposes, aimed at leveraging Waldencast's growth and operational strength.
Waldencast Acquisition Corp. (NASDAQ: WALD) announced its participation in the Cowen 6th Annual Future of the Consumer Conference on May 25, 2022. CEO Michel Brousset will engage in a fireside chat at 2:45 PM ET, with the event accessible via Waldencast's Investor Relations page. The company aims to develop a leading beauty and wellness platform through strategic acquisitions, including its proposed combination with Obagi Global Holdings and Milk Makeup. Waldencast focuses on conscious brands aligning with social responsibility and sustainability.
Waldencast Acquisition Corp. (NASDAQ: WALD) hosted an Analyst Day on April 27, 2022, highlighting its mission to create a premier beauty and wellness platform by merging with Obagi Global Holdings and Milk Makeup. The company focuses on brands that fulfill consumer demands for social responsibility and sustainability. Waldencast filed a registration statement with the SEC in February 2022, outlining the proposed transactions and relevant financial details. Investors are encouraged to review the proxy statement for important information regarding the mergers and associated risks.
Milk Makeup has appointed Nilofer Vahora as its new Chief Marketing Officer (CMO). Vahora brings 14 years of experience from her previous role at Shiseido. This strategic hire follows Waldencast Acquisition Corp.'s $1.2 billion business combination with Milk Makeup and Obagi, aimed at creating a global beauty platform. Both the CEO and co-founder of Milk Makeup expressed confidence in Vahora's ability to drive growth while staying true to the brand's values of clean, vegan, and cruelty-free products.
Waldencast Acquisition Corp. (NASDAQ: WALD) has announced that CEO Michel Brousset will participate in investor meetings and a fireside chat at the D.A. Davidson 5th Annual Consumer Growth Conference on March 10, 2022. Waldencast will also join Evercore ISI CPG Growth Day on March 22, 2022. The discussions aim to promote Waldencast's vision of building a best-in-class beauty and wellness operating platform through partnerships with purpose-driven brands like Obagi and Milk Makeup. Key financial documents regarding these proposed transactions have been filed with the SEC.
Waldencast Acquisition Corp. (NASDAQ: WALD) has announced a definitive business combination with Obagi and Milk Makeup, valued at approximately $1.2 billion. The merger aims to establish a global beauty platform focused on high-growth, purpose-driven brands. The transaction will be funded through a combination of IPO cash, Forward Purchase Agreements, and rollover equity. Waldencast's leadership will include industry veterans, with the goal of driving growth and shareholder value. The merger is expected to close in the first half of 2022, pending shareholder approval.